Data story · Oklahoma syringe services, 2021 to 2026

Oklahoma leads the nation in hepatitis C deaths. On July 1, its legal protection for clean needle programs lapsed.

The 2021 law that let groups hand out sterile syringes had a five-year sunset, and lawmakers let it pass without renewal. Here is what the state’s own data and decades of research say about bringing it back.

#1Highest hepatitis C death rate of any state, every year 2017–2023
3.5×Oklahoma’s rate vs the U.S. in 2023: 8.94 vs 2.52 deaths per 100,000
July 1The day in 2026 the legal protection for syringe programs lapsed

Chapter01

The lapse

In 2021 Oklahoma made it legal for registered groups to hand out sterile syringes. Lawmakers wrote a five-year expiration date into the law. It ran out on July 1, 2026, and nobody renewed it.

The bill had an unusual starting point. Its sponsors filed it to protect police officers from needle-stick injuries. The expiration date was meant to make lawmakers come back after five years and check whether the programs had helped. One of those sponsors, former Rep. Carol Bush, now says: “I’m not sure that conversation ever happened.”

  1. April 20, 2021
    SB 511 takes effect. Churches, nonprofits, tribes and health departments may register and offer harm-reduction services. No state money may buy syringes.
  2. 2022 to 2025
    Registered programs give out an estimated 1.25 million sterile syringes and reach more than 8,800 people. One group alone reaches all 77 counties.
  3. 2026 session
    HB 2012 would have removed the deadline. The House passed a one-year extension instead. The Senate never voted on it.
  4. July 1, 2026
    The protection expires. Handing out syringes is again distributing drug paraphernalia: up to a year in jail and a $10,000 fine.

What the programs reported, 2022 to 2024

People served
8,896
Four registered programs. Oklahoma House interim study
Sterile syringes
578,330
Same programs, same period. Oklahoma House
Naloxone kits
25,125
Two doses each. Oklahoma House
Referrals to other services
1,528
Such as HIV and STI testing or substance use education. Oklahoma House

These are the programs’ own counts. They reported them to the Healthy Minds Policy Initiative, and no one has audited them. The programs also reported 1,212 overdose reversals with naloxone they gave out. We list that figure here but don’t rely on it anywhere in this story.

Chapter02

The burden

Oklahoma has had the highest hepatitis C death rate of any state every year from 2017 to 2023. In 2023, 447 Oklahomans died with hepatitis C listed as a cause of death. That rate was 8.94 per 100,000, 3.5 times the national rate.

The next-highest jurisdiction in 2023, District of Columbia, was at 7.56. Across those seven years, 3,681 Oklahomans died with the virus. Hepatitis C is curable, and it spreads through blood.

Oklahoma has the highest hepatitis C death rate in the country
Deaths with hepatitis C listed as a cause, per 100,000 residents, age-adjusted, 2023. All 50 states and D.C.

Sources: Viral Hepatitis Surveillance Report (2021 and 2023 editions). All sources and caveats

First in the nation every year since at least 2017
Hepatitis C death rate per 100,000, age-adjusted, Oklahoma and the United States

Sources: Viral Hepatitis Surveillance Report (2021 and 2023 editions). All sources and caveats

When doctors report a new hepatitis C infection, they record how the person was exposed. In 2023, that information was missing for 3,230 cases. Of the 1,736 cases where it was recorded, 43% involved injecting drugs, more than any other risk on CDC’s list. These are national figures; CDC does not publish them by state.

Oklahoma also reports more new chronic hepatitis C cases per person than any other state that reports them: 145.5 per 100,000 in 2023, against 36.2 nationally.

Oklahoma now reports more new chronic hepatitis C cases per person than any other reporting state
Newly reported chronic hepatitis C cases per 100,000 residents, 2021 and 2023, Oklahoma and its neighbors

Sources: Viral Hepatitis Surveillance Report (2021 and 2023 editions). All sources and caveats

Read this chart carefully. Oklahoma’s rate went from 55.1 to 145.5 in two years. A rise in reported cases can mean more testing as well as more infection, and these numbers can’t tell the two apart. We treat this as evidence of how many people need care, not as proof that the virus is spreading faster.

Chapter03

The evidence

Syringe programs are among the most studied public health measures. The research supports them, though not equally on every outcome. We show where the evidence is strong and where it is thin.

For HIV, the higher-quality studies in a 2014 meta-analysis found 58% lower risk of infection for people using syringe programs. For hepatitis C, a 2017 Cochrane review found that syringe access alone has weak evidence. Combined with medication for opioid addiction (methadone or buprenorphine), it found a 74% lower risk. That combination is the point. A syringe program is often the first health service a person who injects drugs will walk into, and it is where they can be offered that treatment.

What the research finds, with its uncertainty shown
Risk of infection with each measure compared with without it. Squares are estimates, lines are 95% intervals. Left of 1 means lower risk

Sources: Peer-reviewed studies (PubMed records). All sources and caveats

More likely to enter treatment
5×
New exchange users vs people who never used one, Seattle. One observational study. Hagan 2000
Entered treatment within a week
40%
Exchange clients given a case manager, vs 26% with a referral alone. Randomized trial, Baltimore. Strathdee 2006
Change in arrests near the exchange
None
Arrest trends near Baltimore’s exchange matched the rest of the city. Marx 2000

How strong is this? Almost none of this research is randomized; you can’t randomly deny people clean needles. Most estimates come from comparing people who used programs with people who didn’t, and those groups can differ in other ways. That is why every estimate above shows its interval. The “five times” figure is widely repeated, but it comes from a single city’s study. The Baltimore trial suggests the referral itself matters: treatment entry rose most when programs offered active help such as rides to appointments.

Chapter04

When access ends

The clearest evidence of what syringe access prevents comes from places that went without it.

Scott County, Indiana · 2014–2015

215

HIV infections in one rural county’s outbreak

Indiana had no legal syringe program. An outbreak spread through a network of people injecting prescription opioids, and 92.3% of those diagnosed also had hepatitis C. The state’s first syringe program opened only after the governor declared a public health emergency on March 26, 2015. A Yale model estimates that responding by January 2013 could have prevented at least 127 infections.

Gonsalves 2018 · Peters 2016, NEJM

Kanawha County, West Virginia · 2019–2021

85

people in an HIV outbreak, after the county health department suspended its syringe program in March 2018

Before the outbreak, the county diagnosed fewer than five HIV cases a year among people who inject drugs. In the first ten months of 2019 it diagnosed 11. When CDC investigators interviewed people who inject drugs, they reported sharing syringes “mainly because of limited access to sterile syringes after SSP closures.”

CDC, MMWR 71(2), 2022

What these cases can and can’t show. Neither outbreak proves that one closure caused it. Kanawha’s also overlapped with the COVID-19 pandemic. But both fit the same pattern: shared syringes, then a fast-moving outbreak, in places without legal access. Hepatitis C and HIV both spread through shared needles, and Oklahoma already has the highest hepatitis C death rate in the country.

Chapter05

The neighbors

Oklahoma now sits among neighbors that mostly restrict syringe access too. Colorado and New Mexico authorize it by statute. Arkansas allows it indirectly, Texas allows a single county pilot, and Kansas and Missouri don’t authorize it at all.

Since July 1, Oklahoma has joined the states with no legal syringe access
Whether state law authorizes syringe services programs, Oklahoma and the six states that border it, with each state's 2023 hepatitis C death rate

Sources: Syringe Services Programs: Summary of State Laws (June 2026), Viral Hepatitis Surveillance Report (2021 and 2023 editions). All sources and caveats

Oklahoma’s 2023 hepatitis C death rate (8.94) is about double the next-highest of its neighbors, New Mexico (4.32). States differ in many ways besides their syringe laws, so this map shows where Oklahoma stands. It doesn’t prove what caused the gap.

A note on overdoses. Overdose deaths are falling across the country, and Oklahoma is no exception. As of May 2026, its 12-month count was 40% below its May 2023 peak. The U.S. as a whole was 41% below its own peak. The highest rates in the region are in Colorado and New Mexico, both states where syringe programs are legal. That pattern follows the drug supply: fentanyl reached western markets later. Syringe laws don’t explain it either way, so we don’t use overdose deaths to argue for syringe programs. What the programs add on overdoses is naloxone, the overdose-reversal drug, and the people trained to use it.

Overdose deaths are falling everywhere, including here
Drug overdose deaths in the previous 12 months per 100,000 residents, by month. Oklahoma, the U.S., and neighboring states in gray

Sources: Provisional drug overdose death counts (VSRR), Population estimates, Vintage 2025. All sources and caveats

Chapter06

The ask

Oklahoma tried this for five years. The sunset was meant to prompt a review, and one of the law’s own sponsors isn’t sure it ever happened. Here is what a renewal should do.

  1. Restore the legal protection without an expiration date.As HB 2012 was first written. Programs can’t build trust, hire staff or keep clinic partners while they face a deadline every few years.
  2. Pair syringe access with testing and treatment.The hepatitis C evidence is strongest for syringe access combined with medication for opioid addiction (74% lower risk). Let programs connect people directly to that medication and to hepatitis C cure.
  3. Build in the review the sponsors intended.Keep state registration, and require programs to report what lawmakers will want to know next time: people tested, people linked to treatment, people cured. Then lawmakers can judge the programs on outcomes.

Oklahoma has had the country’s highest hepatitis C death rate every year in the data. It doesn’t need to wait for its own Scott County before acting.